NCT01337115

Brief Summary

The purpose of this study is to determine if the addition of a sciatic nerve block (SNB) to a continuous femoral nerve block (CFNB) improves post-operative analgesia after knee arthroplasty.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at below P25 for not_applicable postoperative-pain

Timeline
Completed

Started Apr 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

April 15, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 18, 2011

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
4 months until next milestone

Results Posted

Study results publicly available

June 19, 2012

Completed
Last Updated

June 19, 2012

Status Verified

May 1, 2012

Enrollment Period

10 months

First QC Date

April 15, 2011

Results QC Date

March 21, 2012

Last Update Submit

May 17, 2012

Conditions

Keywords

Postoperative painKnee arthroplastyPeripheral nerve blocksSciatic nerve blockFemoral nerve block

Outcome Measures

Primary Outcomes (3)

  • Visual Analogue Scores (VAS) - Pain Scores Measured in mm (0-100)

    Pain scores measured by Visual Analogue Score (VAS) scale at 15-30min after Post anesthesia care unit (PACU) arrival VAS is a 100mm scale to measure pain. 0mm - no pain 100mm - worst possible pain

    15-30 min after arrival on post anesthesia care unit (PACU)

  • VAS Results - Pain Measured in mm (0-100)

    VAS pain scores are measured by blinded investigators 12h after surgery . VAS scale: 0 - no pain 100 - worst possible pain

    12h after surgery

  • VAS Results - Pain Scores Measured in mm (0-100)

    VAS pain scores are measured by blinded investigators 24h after surgery . VAS scale: 0 - no pain 100 - worst possible pain

    24h after surgery

Secondary Outcomes (1)

  • Satisfaction With Anesthesia Technique in Each Arm of the Study

    1 month after surgery

Study Arms (2)

Continuous femoral nerve block (CFNB)

ACTIVE COMPARATOR

A continuous femoral nerve block is performed for peri-operative analgesia and a bolus of 30 ml of ropivacaine 0.375% is injected before induction of general anesthesia and surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in post anesthesia care unit (PACU) and maintained for 48h

Procedure: CFNB

Single shot SNB plus CFNB

EXPERIMENTAL

A single shot sciatic nerve block (SNB) is performed before surgery with 25ml of 0.2% ropivacaine in addition to the continuous femoral nerve block (CFNB) performed in the control group before induction of general anesthesia and surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in Post anesthesia care unit (PACU) and maintained for 48h

Procedure: SNB plus CFNB

Interventions

SNB plus CFNBPROCEDURE

A single shot sciatic nerve block (SNB) is performed with 25 ml of 0.2% ropivacaine before surgery in addition to an isolated continuous femoral nerve block (CFNB) in the control group

Also known as: Peripheral nerve blocks, Local anesthetics, Ropivacaine, Femoral nerve block, Sciatic nerve block
Single shot SNB plus CFNB
CFNBPROCEDURE

A continuous femoral nerve block is performed for peri-operative analgesia and a bolus of 30 ml of ropivacaine 0.375% is injected before induction of general anesthesia and surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in post anesthesia care unit (PACU) and maintained for 48h

Also known as: Peripheral nerve blocks, Local anesthetics, Ropivacaine, Femoral nerve block
Continuous femoral nerve block (CFNB)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Unilateral total knee replacement

You may not qualify if:

  • Contra-indication for general anesthesia
  • Infection on puncture site
  • Coagulation disorders
  • Pre-existent neuropathies
  • Allergies to local anesthetics, paracetamol, diclofenac and tramadol
  • Severe dyspepsia
  • Less than 50kg weigh
  • Body Mass Index (BMI) greater than 40
  • American Society of Anesthesiologists (ASA) Physical Status 4 or 5
  • Absence of capacity to use the Visual Analog Score (VAS) scale
  • Refusal to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Hospitalar do Porto, Serviço de Anestesia

Porto, Porto District, 4099-001, Portugal

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Anesthetics, LocalRopivacaine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic UsesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Limitations and Caveats

Difficulties in contacting patients by phone and getting reliable answers limit the value of the patient satisfaction parameter. No analysis was made on the effect of nerve blocks on rehabilitation

Results Point of Contact

Title
Dr Raul Carvalho
Organization
Centro Hospitalar do Porto

Study Officials

  • Raul MS Carvalho, MD

    Centro Hospitalar do Porto

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiology Consultant

Study Record Dates

First Submitted

April 15, 2011

First Posted

April 18, 2011

Study Start

April 1, 2011

Primary Completion

February 1, 2012

Study Completion

March 1, 2012

Last Updated

June 19, 2012

Results First Posted

June 19, 2012

Record last verified: 2012-05

Locations